Compare Edwards Lifesciences Corporation Common Stock (EW) vs UBS Group AG Registered Ordinary Shares (UBS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Edwards Lifesciences Corporation Common Stock vs UBS Group AG Registered Ordinary Shares — how do they compare? Edwards Lifesciences Corporation Common Stock trades at $85.19 (market cap $48.56B), while UBS Group AG Registered Ordinary Shares trades at $48.17 (market cap $142.70B). The key difference: UBS Group AG Registered Ordinary Shares is far larger — about 2.9× Edwards Lifesciences Corporation Common Stock's market cap, and UBS Group AG Registered Ordinary Shares pays a 2.34% dividend while Edwards Lifesciences Corporation Common Stock pays none. Which is the better fit depends on your goals.
| EW | UBS | |
|---|---|---|
Market Cap | $48.56B | $142.70B |
Volume | 6,520,488 | 2,096,090 |
Sector | Health | Financials |
52-Week High | $95.18 | $55.72 |
52-Week Low | $72.65 | $36.41 |
Enterprise Value | $45.01B | $314.41B |
Typical Hold Time | — | 1 Days |
Dividend Yield | — | 2.34% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Edwards Lifesciences Corporation Common Stock
Edwards Lifesciences develops medical technologies for structural heart disease. Its products include transcatheter aortic-valve replacement, mitral and tricuspid therapies, and surgical structural-heart technologies.
Read more on EW →About UBS Group AG Registered Ordinary Shares
UBS is a global financial services company focused on wealth management, investment banking, and asset management. It serves private, corporate, and institutional clients.
Read more on UBS →
